These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18983287)

  • 1. Brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide show a different profile in response to acute decompensated heart failure treatment.
    Di Somma S; Magrini L; Tabacco F; Marino R; Talucci V; Marrocco F; Cardelli P; Ferri E; Pittoni V
    Congest Heart Fail; 2008; 14(5):245-50. PubMed ID: 18983287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.
    Fitzgerald RL; Cremo R; Gardetto N; Chiu A; Clopton P; Bhalla V; Maisel AS
    Am Heart J; 2005 Sep; 150(3):471-7. PubMed ID: 16169326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BNP in the diagnosis and risk stratification of heart failure.
    Moe GW
    Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
    Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
    Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of N-terminal proB-type natriuretic peptide.
    Costello-Boerrigter LC; Burnett JC
    Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):194-201. PubMed ID: 16265483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of brain natriuretic peptide in the management of acute and chronic heart failure in outpatients.
    Safley DM; McCullough PA
    Heart Fail Monit; 2003; 4(1):13-20. PubMed ID: 12808480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health gains by using natriuretic peptides in diagnosis, prognosis and treatment.
    Richards M; Troughton R; Lainchbury J; Doughty R; Wright S
    Scand J Clin Lab Invest Suppl; 2005; 240():129-37. PubMed ID: 16112970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptides: a diagnostic breakthrough for clinicians.
    McCullough PA; Omland T; Maisel AS
    Rev Cardiovasc Med; 2003; 4(2):72-80. PubMed ID: 12776016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Brain natriuretic peptide in acute coronary syndromes: utility of NT-pro BNP assay].
    Ollivier JP; Revel F
    Bull Acad Natl Med; 2004; 188(9):1529-38; discussion 1538-40. PubMed ID: 15997622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent high NTpro-BNP concentration as a negative prognostic factor in patients with decompensated heart failure.
    Kubler P; Petruk-Kowalczyk J; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Kardiol Pol; 2006 Mar; 64(3):250-6; discussion 257-8. PubMed ID: 16583323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of patients with heart failure.
    Mair J
    Scand J Clin Lab Invest Suppl; 2005; 240():99-106. PubMed ID: 16112966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical role of natriuretic peptides--importance of BNP and NT-proBNP. Implications in heart failure and acute coronary syndrome.
    Machado M; Falcão LM; Ravara L
    Rev Port Cardiol; 2004; 23(7-8):1005-32. PubMed ID: 15478326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consensus document. Type B natriuretic peptide in the Italian cardiology clinical reality: update of the experience].
    Ital Heart J Suppl; 2003 Oct; 4(10):850-61. PubMed ID: 14664297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics in N-terminal pro-brain natriuretic peptide concentration in patients with non-ST-elevation acute coronary syndrome.
    Riezebos RK; Ronner E; de Boer BA; Slaats EH; Tijssen JG; Laarman GJ
    Am Heart J; 2005 Dec; 150(6):1255-9. PubMed ID: 16338268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure.
    O'Neill JO; Bott-Silverman CE; McRae AT; Troughton RW; Ng K; Starling RC; Young JB
    Am Heart J; 2005 Feb; 149(2):363-9. PubMed ID: 15846278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure.
    Potapov EV; Hennig F; Wagner FD; Volk HD; Sodian R; Hausmann H; Lehmkuhl HB; Hetzer R
    Eur J Cardiothorac Surg; 2005 May; 27(5):899-905. PubMed ID: 15848333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT-proBNP in heart failure: therapy decisions and monitoring.
    Richards M; Troughton RW
    Eur J Heart Fail; 2004 Mar; 6(3):351-4. PubMed ID: 14987587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004?
    Rodeheffer RJ
    J Am Coll Cardiol; 2004 Aug; 44(4):740-9. PubMed ID: 15312852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.